2026年2月20日, 印度第一家公开上市的生育提供商, IVF与妇女健康组织(Gaudium IVF & Wome Health)在2026年2月20日启动IPO, Gaudium IVF & Women Health, India’s first publicly listed fertility provider, launches its IPO on Feb. 20, 2026, raising ₹165 crore.

迪姆 IVF & Women Health将于2026年2月20日发起IPO,每股价格为75-79卢比,筹集了165亿卢比. Gaudium IVF & Women Health is launching its IPO on February 20, 2026, with a price band of ₹75 to ₹79 per share, raising ₹165 crore. 该公司是印度第一家公开上市的生育力提供商,将利用收入扩大IVF中心、偿还债务和满足一般需要。 The company, India’s first publicly listed fertility provider, will use proceeds for expanding IVF centers, repaying debt, and general needs. 议题于2月24日结束, 2月25日拨款, 2月27日列入BSE和NSE名单。 The issue closes February 24, with allotment on February 25 and listing on BSE and NSE February 27. 书将于2月18日开放. The anchor book opens February 18. 创办人Manika Khanna博士将把她的股份从99.32%减少到70.73%。 Founder Dr. Manika Khanna will reduce her stake from 99.32% to 70.73%. IPO的灰色市场溢价是低调的,它暗示要贴近发行价格。 The IPO has a muted grey market premium, suggesting a listing near the issue price.